Abstract
In spite of the paramount importance of zinc in biology, dynamic aspects of cellular zinc metabolism remain poorly defined at the molecular level. Investigations with human colon cancer (HT-29) cells establish a total cellular zinc concentration of 264 μM. Remarkably, about 10% of the potential high-affinity zinc-binding sites are not occupied by zinc, resulting in a surplus of 28 μM ligands (average K cd = 83 pM) that ascertain cellular zinc-buffering capacity and maintain the “free” zinc concentration in proliferating cells at picomolar levels (784 pM, pZn = 9.1). This zinc-buffering capacity allows zinc to fluctuate only with relatively small amplitudes (ΔpZn = 0.3; below 1 nM) without significantly perturbing physiological pZn. Thus, the “free” zinc concentrations in resting and differentiated HT-29 cells are 614 pM and 1.25 nM, respectively. The calculation of these “free” zinc concentrations is based on measurements at different concentrations of the fluorogenic zinc-chelating agent and extrapolation to a zero concentration of the agent. It depends on the state of the cell, its buffering capacity, and the zinc dissociation constant of the chelating agent. Zinc induction of thionein (apometallothionein) ensures a surplus of unbound ligands, increases zinc-buffering capacity and the availability of zinc (ΔpZn = 0.8), but preserves the zinc-buffering capacity of the unoccupied high-affinity zinc-binding sites, perhaps for crucial physiological functions. Jointly, metallothionein and thionein function as the major zinc buffer under conditions of increased cellular zinc.
Similar content being viewed by others
Notes
“Free” zinc has been referred to as “freely available,” “labile,” or “rapidly exchangeable” zinc that is readily bound to chelating agents. Each term is an operational definition and has its limitations. For the lack of a better term, “free” zinc is used in this work, albeit with the understanding that the chemical nature of the ligands of ionic zinc is not known. “Rapidly exchangeable” implies certain kinetic mechanisms. Thus, there are pools of thermodynamically tightly bound zinc with considerable “kinetic lability” in exchange reactions. A prime example is metallothionein.
References
O’Halloran TV, Culotta VC (2000) J Biol Chem 275:25057–25060
Thompson RB (2005) Curr Opin Chem Biol 9:526–532
Gaither LA, Eide DJ (2001) Biometals 14:251–270
Outten CE, O’Halloran TV (2001) Science 292:2488–2492
Peck EJ Jr, Ray WJ Jr (1971) J Biol Chem 246:1160–1167
Simons TJB (1991) J Membr Biol 123:63–71
Benters J, Flögel U, Schäfer T, Leibfritz D, Hechtenberg S, Beyersmann D (1997) Biochem J 322:793–799
Adebodun F, Post JF (1995) J Cell Physiol 163:80–86
Atar D, Backx PH, Appel MM, Gao WD, Marban E (1995) J Biol Chem 270:2473–2477
Ayaz M, Turan B (2006) Am J Physiol Heart Circ Physiol 290:H1071–H1080
Bozym RA, Thompson RB, Stoddard AK, Fierke CA (2006) ACS Chem Biol 1:103–111
Frederickson CJ, Bush AI (2001) Biometals 14:353–366
Frederickson CJ, Koh J-Y, Bush AI (2005) Nat Rev Neurosci 6:449–462
Grynkiewicz G, Poenie M, Tsien RY (1985) J Biol Chem 260:3440–3450
Hitomi Y, Outten CE, O’Halloran TV (2001) J Am Chem Soc 123:8614–8615
Hirano T, Kikuchi K, Urano Y, Nagano T (2002) J Am Chem Soc 124:6555–6562
Shaw CF, Laib JE, Savas M, Petering DH (1990) Inorg Chem 29:403–408
Smith PK, Krohn RJ, Hermanson GT, Mallia AK, Gartner FH, Provenzano M, Fujimoto EK, Goeke NM, Olson GJ, Klenk DC (1985) Anal Biochem 150:76–85
Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E (2003) Anal Biochem 312:224–227
Yang Y, Maret W, Vallee BL (2001) Proc Natl Acad Sci USA 98:5556–5559
Raaflaub J (1956) Methods Biochem Anal 3:301–325
Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TG, Jones DP (1999) Free Radical Biol Med 27:1208–1218
Nagel WW, Vallee BL (1995) Proc Natl Acad Sci USA 92:579–583
Neutra M, Louvard D (1989) In: Matlin KS, Valentich JD (eds) Functional epithelial cells in culture. Liss, New York, pp 363–398
Gee KR, Zhou Z-L, Qian W-E, Kennedy R (2002) J Am Chem Soc 124:776–778
Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, Kaczmarek LK, Weiss JH (2003) Proc Natl Acad Sci USA 100:6157–6162
Kimura E, Shiota T, Koike T, Shiro M, Kodoma M (1990) J Am Chem Soc 112:5805–5811
Schwarzenbach G, Freitag E (1951) Helv Chim Acta 34:1492–1502
Chaberek S, Martell AE (1952) J Am Chem Soc 74:6228–6231
Frausto da Silva JJR, Calado JG (1963) Rev Port Quim 5:121–128
Martell AE, Smith RM (2001) NIST critical stability constants of metal complexes. NIST standard reference database 46, version 6.0
Anderegg G (1964) Helv Chim Acta 47:1801–1814
Holloway JH, Reilley CN (1960) Anal Chem 32:249–256
Gee KR, Zhou ZL, Ton-That D, Sensi SL, Weiss JH (2002) Cell Calcium 31:245–251
Kägi JHR (1993) In: Suzuki KT, Imura N, Kimura M (eds) Metallothionein III. Biological roles and medical implications. Birkhäuser, Basel, pp 29–55
Krężel A, Wójcik J, Maciejczyk M, Bal W (2003) Chem Commun 704–705
Rabenstein DL, Isab AA (1980) FEBS Lett 121:61–64
Günes C, Heuchel R, Georgiev O, Müller KH, Lichtlen P, Blüthmann H, Marino S, Aguzzi A, Schaffner W (1998) EMBO J 17:2846–2854
Krężel A, Bal W (1999) Acta Biochim Pol 46:567–580
Krężel A, Bal W (2004) Bioinorg Chem Appl 2:293–305
Chang CJ, Nolan EM, Jaworski J, Burdette SC, Sheng M, Lippard SJ (2004) Chem Biol 11:203–210
Kikuchi K, Komatsu K, Nagano T (2004) Curr Opin Chem Biol 8:182–191
Dineley KE, Malaiyandi LM, Reynolds IJ (2002) Mol Pharmacol 62:618–627
Haase H, Hebel S, Engelhardt G, Rink L (2006) Anal Biochem 352:222–230
Maret W, Jacob C, Vallee BL, Fischer EH (1999) Proc Natl Acad Sci USA 96:1936–1940
Knipp M, Charnock JM, Garner CD, Vasak M (2001) J Biol Chem 276:40449–40456
Haase H, Maret W (2003) Exp Cell Res 291:289–298
Heinz U, Kiefer M, Tholey A, Adolph H-W (2005) J Biol Chem 280:3197–3207
Thomas RC, Coles JA, Deitmer JW (1991) Nature 350:564
Acknowledgements
This work was supported by National Institutes of Health Grant GM 065388 to WM. We thank Dr. V.M. Sadagopa Ramanujam, Associate Professor, Department for Preventive Medicine and Community Health, The University of Texas Medical Branch, for metal analyses by atomic absorption spectrophotometry (supported by the Human Nutrition Research Facility) and Drs. Christopher J. Frederickson and Hans-Werner Adolph for discussions.
Author information
Authors and Affiliations
Corresponding author
Appendices
Appendix 1
Variation of “free” zinc in the presence of two ligands, where L1 represents the bulk of cellular zinc proteins and L2 represents the fluorescent probe. The simulations demonstrate that under zinc-buffering conditions extrapolation with a linear function (Fig. 2) is permissible. The concentrations of total zinc and probe correspond to those experimentally determined. The buffered system (Fig. 7, panel A) corresponds to the experimental condition of an excess of unbound ligands (292 μM, corresponding to the sum of 264 μM occupied and 28 μM surplus ligands), whereas the unbuffered (264 μM) system (Fig. 7, panel B) corresponds to a fictional condition without additional zinc-buffering capacity. Intermediate conditions with L1 values of 270, 275, 280, 285, 290, and 295 μM are represented in Fig. 7, panel C, curves a–e, respectively.
Appendix 2
Simulation of the Zincon–zinc titration (Fig. 8) in the presence of intracellular unbound ligands with various affinities for zinc and experimentally determined parameters (Fig. 4).
Rights and permissions
About this article
Cite this article
Krężel, A., Maret, W. Zinc-buffering capacity of a eukaryotic cell at physiological pZn. J Biol Inorg Chem 11, 1049–1062 (2006). https://doi.org/10.1007/s00775-006-0150-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-006-0150-5